Ramy Sedhom, Director of Medical Oncology and Palliative Care at Penn Medicine Princeton Health, University of Pennsylvania Health System, shared a post on X about a paper by Linda D. Bosserman et al. published in the Journal of Clinical Oncology:
“Love this editorial calling out the grey in hormone replacement therapy after breast cancer, and the importance of shared decision making.”
Title: Menopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibition
Authors: Linda D. Bosserman and Don S. Dizon
Read the Full Article.
